Asthma is a chronic inflammatory syndrome of the airways which afflicts over 12 million people in the USA. It is characterized physiologically by recurrent airway obstruction which resolves spontaneously or as a result of treatment, Its etiology remains unknown. Despite the lack of understanding of is etiology, there are effective treatment for asthma. There are three main classes of asthma treatment in use today, inhaled B-agonists, inhaled corticosteroids and leukotriene modifiers; a given patient may use one, two or all of these types of treatments. The treatments are not uniformly effective; they vary in their efficacy amongst individuals and there are compelling preliminary data (outlined herein) suggesting that at least half of the variance in the treatment response may be genetic in origin; our proposal is structured to identify the genes responsible for this variable response. Our proposed approach is straightforward. For each of the three major asthma treatment pathways, we will: 1)Define a panel of target genes which are likely to modify the function of the pathway; 2) Scan these targets for DNA sequence variants; 3) As variants are identified they will ascertain which, if any, alter either the level of expression of function of their encoded proteins; 4) Genotype, at loci associated with functional implications in vitro, will be ascertained in asthma patients, who have been (existing patient resources) or will be (to be acquired patient resources) phenotyped with respect to the response to treatment with the class of asthma medication of interest;5) The investigators will use a case -control association approach to define specific genotypes associated with either a salutary treatment response or lack thereof. (In newly acquired populations they will use transmission disequilibrium testing); 6) Once genotypes associated with potential pharmacogentic predictive value are defined they will collaborate with the NIH sponsored Asthma Clinical Research Network to study patients with specific genotypes to determine if they provide predictive information about treatment responses; 7) Our approach will allow us to ascertain the pharmacogenetic basis for the observed variability in asthma treatment responses.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project--Cooperative Agreements (U01)
Project #
3U01HL065899-04S1
Application #
6899514
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Banks-Schlegel, Susan P
Project Start
2000-04-01
Project End
2005-07-31
Budget Start
2004-04-01
Budget End
2005-07-31
Support Year
4
Fiscal Year
2004
Total Cost
$1,618,806
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Choi, Jihoon; Tantisira, Kelan G; Duan, Qing Ling (2018) Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes. Pharmacogenomics J :
Sharma, Amitabh; Halu, Arda; Decano, Julius L et al. (2018) Controllability in an islet specific regulatory network identifies the transcriptional factor NFATC4, which regulates Type 2 Diabetes associated genes. NPJ Syst Biol Appl 4:25
McGeachie, Michael J; Clemmer, George L; Hayete, Boris et al. (2018) Systems biology and in vitro validation identifies family with sequence similarity 129 member A (FAM129A) as an asthma steroid response modulator. J Allergy Clin Immunol 142:1479-1488.e12
Kho, Alvin T; McGeachie, Michael J; Moore, Kip G et al. (2018) Circulating microRNAs and prediction of asthma exacerbation in childhood asthma. Respir Res 19:128
Park, Heung-Woo; Song, Woo-Jung; Cho, Sang-Heon et al. (2018) Assessment of genetic factor and depression interactions for asthma symptom severity in cohorts of childhood and elderly asthmatics. Exp Mol Med 50:77
Qiu, Weiliang; Guo, Feng; Glass, Kimberly et al. (2018) Differential connectivity of gene regulatory networks distinguishes corticosteroid response in asthma. J Allergy Clin Immunol 141:1250-1258
McGeachie, Michael J; Davis, Joshua S; Kho, Alvin T et al. (2017) Asthma remission: Predicting future airways responsiveness using an miRNA network. J Allergy Clin Immunol 140:598-600.e8
Park, H-W; Tse, S; Yang, W et al. (2017) A genetic factor associated with low final bone mineral density in children after a long-term glucocorticoids treatment. Pharmacogenomics J 17:180-185
McGeachie, Michael J; Yates, Katherine P; Zhou, Xiaobo et al. (2016) Genetics and Genomics of Longitudinal Lung Function Patterns in Individuals with Asthma. Am J Respir Crit Care Med 194:1465-1474
McGeachie, M J; Yates, K P; Zhou, X et al. (2016) Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma. N Engl J Med 374:1842-1852

Showing the most recent 10 out of 233 publications